Cargando…
Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer
Background: Despite substantial effort, there remains a lack of biomarker-based, clinically relevant testing for the accurate, non-invasive diagnostic or prognostic profiling of epithelial ovarian cancers (EOC). Our previous work demonstrated that whilst the inflammatory marker C-X-C motif chemokine...
Autores principales: | Kang, Sung-Woog, Rainczuk, Adam, Oehler, Martin K., Jobling, Thomas W., Plebanski, Magdalena, Stephens, Andrew N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230042/ https://www.ncbi.nlm.nih.gov/pubmed/34200333 http://dx.doi.org/10.3390/diagnostics11061048 |
Ejemplares similares
-
A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer
por: Stephens, Andrew N., et al.
Publicado: (2023) -
Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
por: Bilandzic, Maree, et al.
Publicado: (2019) -
Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2018) -
Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021) -
Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer
por: Weiland, Florian, et al.
Publicado: (2020)